Terms: = Lymphoma AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Prognosis
363 results:
1. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
[TBL] [Abstract] [Full Text] [Related]
2. High-dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic study.
Chen X; Li J; Yu L; Hu W; Cai J; Wang Z; Chen C; Zhang X; Xie Y; Wu K; Mo Y; Chen J; Shen S
Br J Haematol; 2024 Apr; 204(4):1354-1366. PubMed ID: 38432257
[TBL] [Abstract] [Full Text] [Related]
3. Predictive and prognostic molecular biomarkers in lymphomas.
Iorgulescu JB; Medeiros LJ; Patel KP
Pathology; 2024 Mar; 56(2):239-258. PubMed ID: 38216400
[TBL] [Abstract] [Full Text] [Related]
4. Deciphering Acute Myeloid Leukemia Associated Transcription Factors in Human Primary CD34+ Hematopoietic Stem/Progenitor Cells.
Kreissig S; Windisch R; Wichmann C
Cells; 2023 Dec; 13(1):. PubMed ID: 38201282
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical characteristics and prognosis of 28 cases of infant acute lymphoblastic leukemia].
Shi Y; Lu Y; Zhang RD; Zhang YY; Lin W; Yu JJ; Wu Y; Fan J; Qi PJ; Huang PL; Cai LX; Huang Q; Zhang P; Sun YM; Liu Y; Zheng HY
Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):49-54. PubMed ID: 38154977
[No Abstract] [Full Text] [Related]
6. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical Analysis of Infants with Acute Lymphoblastic Leukemia (18 cases)].
Li KL; Xiong H; Li H; Wang Z; Chen Z; Yang L; Lu WJ; Qi SS; Sun M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1670-1675. PubMed ID: 38071044
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical analysis of long-term survival and influencing factors of chimeric antigen receptor T-cell therapy in relapsed/refractory acute B-cell lymphoblastic leukemia].
Wang Y; Gao QY; Wang H; Zhang D; Gao Y; Miao YD; Zhai XH; Hu XX; Rui XL; Zhang WH
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):800-804. PubMed ID: 38049330
[No Abstract] [Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia.
Tian J; Wei A; Wang B; Yang J; Zheng H; Qin M
Ann Hematol; 2024 Jan; 103(1):297-305. PubMed ID: 37991510
[TBL] [Abstract] [Full Text] [Related]
10. Paediatric B lymphoblastic leukaemia with hyperdiploidy and a false-positive kmt2a fluorescence in situ hybridization result.
Nunn J; Adayapalam N; Riyat S; Seymour L; Williams B; Rehn J; White D; Moore AS; Tsuchiya K
Cancer Genet; 2023 Nov; 278-279():80-83. PubMed ID: 37742392
[TBL] [Abstract] [Full Text] [Related]
11. High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia.
Oikonomou A; Valsecchi L; Quadri M; Watrin T; Scharov K; Procopio S; Tu JW; Vogt M; Savino AM; Silvestri D; Valsecchi MG; Biondi A; Borkhardt A; Bhatia S; Cazzaniga G; Fazio G; Bardini M; Palmi C
Biochem Pharmacol; 2023 Nov; 217():115809. PubMed ID: 37717691
[TBL] [Abstract] [Full Text] [Related]
12. Genetic alterations and MRD refine risk assessment for kmt2a-rearranged B-cell precursor ALL in adults: a GRAALL study.
Kim R; Bergugnat H; Pastoret C; Pasquier F; Raffoux E; Larcher L; Passet M; Grardel N; Delabesse E; Kubetzko S; Caye-Eude A; Meyer C; Marschalek R; Lafage-Pochitaloff M; Thiebaut-Bertrand A; Balsat M; Escoffre-Barbe M; Blum S; Baumann M; Banos A; Straetmans N; Gallego-Hernanz MP; Chalandon Y; Graux C; Soulier J; Leguay T; Hunault M; Huguet F; Lhéritier V; Dombret H; Boissel N; Clappier E
Blood; 2023 Nov; 142(21):1806-1817. PubMed ID: 37595275
[TBL] [Abstract] [Full Text] [Related]
13. Rearrangement of
Othman BK; Steiner P; Leivo I; Skálová A
Fetal Pediatr Pathol; 2023 Oct; 42(5):796-807. PubMed ID: 37517063
[No Abstract] [Full Text] [Related]
14. Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
Tsai HK; Gogakos T; Lip V; Tsai JM; Li YD; Fisch AS; Weiss J; Yang W; Grimmett L; DiToro D; Schaefer EJ; Lindsley RC; Tran TH; Caron M; Langlois S; Sinnett D; Pikman Y; Nardi V; Kim AS; Silverman LB; Harris MH
J Mol Diagn; 2023 Sep; 25(9):665-681. PubMed ID: 37419244
[TBL] [Abstract] [Full Text] [Related]
15. A novel prognostic nomogram for adult acute lymphoblastic leukemia: a comprehensive analysis of 321 patients.
Zhang Q; Huang MJ; Wang HY; Wu Y; Chen YZ
Ann Hematol; 2023 Jul; 102(7):1825-1835. PubMed ID: 37173535
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical Analysis of
Song Y; Gong XY; Wei SN; Li QH; Zhang GJ; Wang Y; Wei H; Lin D; Li SZ; Feng SZ; Wang JX; Mi YC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):352-357. PubMed ID: 37096505
[TBL] [Abstract] [Full Text] [Related]
17. Infantile B-lymphoblastic leukemia: a case series and review of the literature.
Mansoor N; Imran S; Maqsood S; Pasha S; Jabbar N
J Int Med Res; 2023 Apr; 51(4):3000605231167789. PubMed ID: 37066443
[TBL] [Abstract] [Full Text] [Related]
18. Proteasome inhibition targets the kmt2a transcriptional complex in acute lymphoblastic leukemia.
Kamens JL; Nance S; Koss C; Xu B; Cotton A; Lam JW; Garfinkle EAR; Nallagatla P; Smith AMR; Mitchell S; Ma J; Currier D; Wright WC; Kavdia K; Pagala VR; Kim W; Wallace LM; Cho JH; Fan Y; Seth A; Twarog N; Choi JK; Obeng EA; Hatley ME; Metzger ML; Inaba H; Jeha S; Rubnitz JE; Peng J; Chen T; Shelat AA; Guy RK; Gruber TA
Nat Commun; 2023 Feb; 14(1):809. PubMed ID: 36781850
[TBL] [Abstract] [Full Text] [Related]
19. [Efficacy and safety of Venetoclax in the treatment of 25 patients with recurrent hematologic malignancies after an allogeneic hematopoietic stem cell transplantation].
Chen X; Liu ZY; Zhang RL; Zhai WH; Ma QL; Pang AM; Yang DL; He Y; Wei JL; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):542-549. PubMed ID: 36709130
[No Abstract] [Full Text] [Related]
20. Successful Retransplantation With Killer Cell Immunoglobulin-like Receptor Ligand-mismatched Cord Blood in Infant Acute Lymphoblastic Leukemia That Relapsed After Transplantation.
Mizuki K; Honda Y; Asai H; Higuchi N; Morita H; Yabe H; Kusuhara K
J Pediatr Hematol Oncol; 2023 May; 45(4):e547-e550. PubMed ID: 36706271
[TBL] [Abstract] [Full Text] [Related]
[Next]
